Reported Earlier, Dexcom Announces Stelo, The First Over-The-Counter Glucose Biosensor In The U.S., Is Now Available For Purchase Without A Prescription
Reported Earlier, Dexcom Announces Stelo, The First Over-The-Counter Glucose Biosensor In The U.S., Is Now Available For Purchase Without A Prescription
如今，德康医疗宣布 Stelo，美国首款非处方葡萄糖生物传感器已经上市，可以无需处方购买。
- Available for purchase today at Stelo.com for people in the U.S. 18 and older not using insulin
- Provides 24/7 powerful and personalized glucose insights directly to a smartphone,* revealing how food, exercise and sleep can affect glucose
- Tracking glucose just got easier, with no prescription and no fingersticks, ever
- Specifically designed to help people with Type 2 diabetes not using insulin and those with prediabetes reach their A1c goals and potentially slow the progression of diabetes.†,1-3
- Stelo.com现在可供美国18岁及以上人群购买，不使用胰岛素
- 提供全天候强大且个性化的血糖信息直接发送到智能手机上，揭示食物、锻炼和睡眠如何影响血糖
- 跟踪血糖变得更加容易，无需处方和指尖采血
- 专门设计帮助不使用胰岛素的2型糖尿病患者和患有糖尿病前期的人达到A1c目标，可能延缓糖尿病的进展†,1-3
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter glucose biosensor in the U.S., is now available for purchase without a prescription4 at Stelo.com.
全球领先的实时连续血糖监测技术公司DexCom, Inc. (纳斯达克：DXCM) 今日宣布，美国首款非处方式血糖生物传感器Stelo现可在Stelo.com购买，无需处方4